Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Clinical trial NCT02456714 · COMPLETED
Trial details
- NCT number
- NCT02456714
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2018-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.